Fermenta Biotech is undertaking a planned partial shutdown of its manufacturing facility at Dahej to carry out capacity increasing measures for Vitamin D3 crystals with effect from October 5, 2021 for an estimated period of 15 days, until October 20, 2021.
Following the previous shutdown in April 2019, which was successfully completed to increase capacity of Vitamin D3 intermediates, the current shutdown is being taken for increasing Vitamin D3 crystals' capacity. Post completion, the company’s production capacity of Vitamin D3 crystals will increase by around 25%. This initiative is part of company’s capacity enhancement strategy to meet the expected increase in peak demand for Vitamin D3 crystals under the current circumstances.
Fermenta Biotech (formerly known as DIL) is engaged in the business of research support services through their subsidiary Research Support International Ltd. (RSIL), manufacture and marketing of enzymes and chemicals through their subsidiary Fermenta Biotech (FBL).
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: